Showing results (91-100 of 134) with videos related to

Sort By:
Pageof 14
Haematologica|November 22, 2011
MicroRNA profiling of follicular lymphoma identifies microRNAs related to cell proliferation and tumor responseWeixin Wang, Meghan Corrigan-Cummins, Justin Hudson, et al.
Blood|April 22, 2009
Differential efficacy of bortezomib plus chemotherapy within molecular subtypes of diffuse large B-cell lymphomaKieron Dunleavy, Stefania Pittaluga, Myron S Czuczman, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 10, 2007
Effective therapy of murine models of human leukemia and lymphoma with radiolabeled anti-CD30 antibody, HeFi-1Meili Zhang, Zhengsheng Yao, Hiral Patel, et al.
The Oncologist|July 9, 2025
First-in-human phase I open-label study of the anti-TIM-3 monoclonal antibody INCAGN02390 in patients with select advanced or metastatic solid tumorsMartin E Gutierrez, Shou-Ching Tang, John D Powderly, et al.
Nature Communications|January 28, 2014
Designing quantum dots for solotronicsJ Kobak, T Smoleński, M Goryca, et al.
Blood|June 26, 2012
Radiation therapy for the management of patients with HTLV-1-associated adult T-cell leukemia/lymphomaCharles B Simone, John C Morris, Donn M Stewart, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 2, 2008
Phase II study of dose-adjusted EPOCH and rituximab in untreated diffuse large B-cell lymphoma with analysis of germinal center and post-germinal center biomarkersWyndham H Wilson, Kieron Dunleavy, Stefania Pittaluga, et al.
Leukemia & Lymphoma|July 13, 2011
Phase I trial of 7-hydroxystaurosporine and fludararbine phosphate: in vivo evidence of 7-hydroxystaurosporine induced apoptosis in chronic lymphocytic leukemiaGerald E Marti, Maryalice Stetler-Stevenson, Nicole Drbohlav Grant, et al.
The New England Journal of Medicine|March 18, 1993
The effects of treatment with interleukin-1 alpha on platelet recovery after high-dose carboplatinJ W Smith, D L Longo, W G Alvord, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 1, 1992
The toxic and hematologic effects of interleukin-1 alpha administered in a phase I trial to patients with advanced malignanciesJ W Smith, W J Urba, B D Curti, et al.
Pageof 14